From the Infectious Diseases Section, Medical Service, Veterans Affairs Medical Center , Washington, DC , USA.
Infect Dis (Lond). 2015 Apr;47(4):267-70. doi: 10.3109/00365548.2014.989540. Epub 2015 Feb 17.
Transarterial chemoembolization (TACE) is an important therapeutic option for patients with hepatocellular carcinoma (HCC). We discuss five patients with HCC and tuberculosis (TB) reactivation following TACE. Screening patients for latent TB infection at diagnosis of cirrhosis or HCC should be considered because of the immunosuppression inherent in both the diseases and their treatments.
经动脉化疗栓塞术(TACE)是治疗肝细胞癌(HCC)患者的重要治疗选择。我们讨论了 5 例 HCC 患者在 TACE 后出现结核(TB)再激活的情况。由于这两种疾病及其治疗都存在固有免疫抑制,因此在诊断肝硬化或 HCC 时应考虑对潜伏性 TB 感染进行筛查。